FAQ
Log In
Sunday 22nd July 2018
News
 › 
 › 

GSK's new chief executive ditches over 30 drug research projects in strategic review

26th July 2017


Click on available sources in right hand menu to see the original article.

Share this page

Comments

There are no comments for this article, be the first to comment!


Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: GSK's new chief executive ditches over 30 drug research projects in strategic review
Author: Eve Doyle
Article Id: 28809
Date Added: 26th Jul 2017

Sources

Reuters News

Actions

Add to scrapbook
Show Comments
Add comment
Find all related articles

Mayden - Innovative cloud-based web development for the healthcare sector
© Mayden Foundation 2018